Cancer Research Technology
Log in Register
Menu

Anti-Cytochrome P450 26C1 [T6P1C7*E7]

Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited

Info

Catalogue Number 152157
Applications IHC WB
Antigen/Gene or Protein Targets Cytochrome P450, family 26, subfamily C, polypeptide 1 (CYP26C1)
Reactivity Human, Mouse and Rat
Relevance CYP26C1 is not expressed in in colorectal cancer but detected in the liver.
Host Mouse
Immunogen Ovalbumin-conjugated synthetic peptide RWELATPAFP (C-terminal sequence)
Positive Control IHC: formalin-fixed, paraffin-embedded human liver sections. western blot: overexpression lysates.
Subclass IgG1 kappa
Myeloma Used P3X63Ag8.653
Recommended Growing Conditions Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM plus 60 ml Fetal Bovine Serum plus 3ml L-Glutamine).
Strain Balb/c
Research Area Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Brown et al. 2014. PLoS One. 9(3):e90776. PMID: 24608339.

The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer.

Europe PMC ID: 24608339


Add a reference

References: 2 entries

Brown et al. 2014. PLoS One. 9(3):e90776. PMID: 24608339.

The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer.


Add a reference